Fight CRC Blog

ESMO Updates

Patients with microsatellite instability (MSI)/mismatch repair deficient (dMMR) colon cancer who undergo surgery may benefit from receiving neoadjuvant immunotherapy. Standard-of-care chemotherapy offers limited benefit to patients with MSI-H/dMMR colon cancer,...

Understanding the ERASur clinical trial

Dr. Miller: The primary objective of ERASur is to answer this question – Do patients with limited metastatic colorectal cancer live longer if we treat all sites of disease with...

Advocacy wins and survivorship

What an exciting month June has been so far! You relentlessly raised your voice alongside the GI community to object to UnitedHealthcare’s prior authorization policy. Advocates sent almost 1,200 action...

A New Era for No Shave November™

After many years of dedicated work and impactful contributions to the fight against cancer, the Matthew Hill Foundation is closing their doors and passing the razor to Fight Colorectal Cancer...

Summer Fundraisers Raise Over $165,000

Fight Colorectal Cancer (Fight CRC) is thrilled to announce the successful conclusion of the 2024 summer fundraising season. Between the capstone Climb for a Cure event, along with several community...

Oracle Health Executive, Finance Expert join Fight CRC Board of Directors

Fight Colorectal Cancer is pleased to announce the newest members to its board of directors: Dr. Nasim Afsar and Dominick Schiano. Both members will serve an initial two-year term on...